Skip to main content
. 2009 May 29;284(22):15299–15307. doi: 10.1074/jbc.M807285200

FIGURE 8.

FIGURE 8.

Mesd antagonizes Wnt3a binding to LRP6 BP1234, BP12, and BP34. Recombinant Mesd (1 μm) is able to compete for rWnt3a (1 μg/ml) binding to BPs in co-immunoprecipitation (Co-IP) (A) and solid phase binding assays (C). B, quantification of results from Co-IP. D, recombinant Mesd (1 μm) is able to compete for Myc-Dkk1 binding to BPs in Co-IP. IP, immunoprecipitation; WB, Western blot.